Clinical Significance of an m6A Reader Gene, IGF2BP2, in Head and Neck Squamous Cell Carcinoma
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Purpose: The importance of N6-methyladenosine (m6A) in tumor recurrence and prognosis has gradually emerged in recent years. The role of IGF2BP2 as one of m6A readers in regulating HNSCC is not clear. We assessed the prognostic role of IGF2BP2 in HNSCC using openly obtainable information from The Cancer Genome Atlas (TCGA). Materials and methods: We used The Cancer Genome Atlas database in conjunction with HNSCC patients sample IHC(n=36)to analyze the expression of IGF2BP2 in HNSCC. Then we used KS test, logistic regression and Forest Map Analysis to find the correlation between IGF2BP2 expression and clinical characteristics. We assessed the role of IGF2BP2 in prognosis by Kaplan-Meier curves and Cox analysis. Finally, we use TCGA data to explore possible carcinogenic mechanisms with multi-GSEA (Gene set enrichment analysis). Results: Analysis of TCGA data and IHC results showed that IGF2BP2 was upregulated in HNSCC, and the expression level was related to T stage. simultaneously, Kaplan-Meier curves and Cox analysis implicated that highly expressed IGF2BP2 correlated with poor prognosis, and IGF2BP2 was an independent risk factor for HNSCC. Gene set enrichment analysis showed that Scavenging and degradation, Synthesis and metabolism, Cell growth, death and motility and Cancer pathways and Others are differentially enriched in IGF2BP2 high-expression phenotype. Conclusion: Our results show that IGF2BP2 plays an important role in tumor progression and may become an important biological prognostic factor for head squamous cell carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., Zhao, B. S., Mesquita, A., Liu, C., Yuan, C. L., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0045-z · Cited by 2,997 · cited 1×
“IGF2BP2 is also an RNA-binding protein (RBP) that serves as a posttranscriptional regulatory factor for mRNA localization, stability, and translational control (Huang et al., 2018).”
BackgroundSelf-citationLncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
Wang, Y., Lu, J.-H., Wu, Q.-N., Jin, Y., Wang, D.-S., Chen, Y.-X., Liu, J., Luo, X.-J., Meng, Q., Pu, H.-Y., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1105-0 · Cited by 507
Self-citationXu, X., Yu, Y., Zong, K., Lv, P., & Gu, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1470-y · Cited by 203
Wu, X., Lu, R., Wang, L., Wang, Y., Dai, Y., Wang, C., Yang, Y., Guo, F., Xue, J., & Yang, D. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27079 · Cited by 40
Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas
Hiramatsu, K., Yoshino, K., Serada, S., Yoshihara, K., Hori, Y., Fujimoto, M., Matsuzaki, S., Egawa-Takata, T., Kobayashi, E., Ueda, Y., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.27 · Cited by 40
CCN6 regulates IGF2BP2 and HMGA2 signaling in metaplastic carcinomas of the breast
McMullen, E. R., Gonzalez, M. E., Skala, S. L., Tran, M., Thomas, D., Djomehri, S. I., Burman, B., Kidwell, K. M., & Kleer, C. G. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4960-2 · Cited by 31
Cited by
Lu, S., Han, L., Hu, X., Sun, T., Xu, D., Li, Y., Chen, Q., Yao, W., He, M., Wang, Z., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01204-0 · Cited by 116
IGF2BP2 promotes the progression of colorectal cancer through a YAP‐dependent mechanism
Cui, J., Tian, J., Wang, W., He, T., Li, X., Gu, C., Wang, L., Wu, J., & Shang, A. (2021) · Cancer Science · doi:10.1111/cas.15083 · Cited by 90
Lin, C.-W., Yang, W.-E., Su, C.-W., Lu, H.-J., Su, S.-C., & Yang, S.-F. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.91786 · Cited by 24
Zhou, L., Li, H., Cai, H., Liu, W., Pan, E., Yu, D., & He, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.809589 · Cited by 24
“The expression of IGF2BP2 is significantly upregulated in head and neck squamous cell carcinoma (HNSC) tissue and predicts a poor prognosis (12).”
Background
Metadata
- Authors
- Deng, X., Jiang, Q., Liu, Z., & Chen, W.
- Venue
- Frontiers in Molecular Biosciences
- Publisher
- Frontiers Media SA
- Published
- 2020-04-24
- Volume
- 7
- Pages
- 68-68
- ISSN
- 2296-889X (ISSN-L)
- OpenAlex
- W3017955894
- Cited by
- 45
- References
- 7
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Significance of an m6A Reader Gene, IGF2BP2, in Head and Neck Squamous Cell Carcinoma. https://app.cochat.ai/papers/10.3389/fmolb.2020.00068
- The paper
- Deng, X., Jiang, Q., Liu, Z., & Chen, W. (2020). Clinical Significance of an m6A Reader Gene, IGF2BP2, in Head and Neck Squamous Cell Carcinoma. Frontiers in Molecular Biosciences. https://doi.org/10.3389/fmolb.2020.00068
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.